News
He said reducing the steps to target dosing could help overcome clinical inertia. "In real-world practice, most patients never achieve the target doses of recommended heart failure medications ...
Crinecerfont vs placebo was associated with lower glucocorticoid dose needs and improved hormone control among pediatric ...
Semaglutide, available under the brand names Ozempic and Wegovy, may help decrease the risk of major adverse cardiovascular ...
HCG, a global leader in the field, has recently reorganised seven smaller agencies into a single, powerful entity with a clear purpose: to accelerate the impact of science for its pharmaceutical ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Since returning to the White House, President Donald Trump has made several moves to crack down on immigration, and one of his efforts was in front of the Supreme Court on Thursday. Several of the ...
Among 35 adults using technosphere insulin in the INHALE-3 trial, 74% increased their daily dose by more than 4 U at 30 weeks. Total daily inhaled insulin dose increased from 36 U at 4 days to 52 ...
Both Luke Jackson (finger) and Chris Martin (elbow) are dealing with injuries, forcing the Rangers to lean on Shawn Armstrong and Jacob Webb to close games temporarily. (May 16) The Cubs' closer ...
Billie Eilish Last week Weeks at no. 1 Weeks on chart B.E.O'Connell, F.B.O'Connell Finneas Darkroom/Interscope/ICLG Week of May 17, 2025 click to see more ...
Morgan Wallen Last week Weeks at no. 1 Weeks on chart Big Loud/Mercury/Republic Week of May 17, 2025 click to see more Big Loud/Mercury/Republic Rimas ...
Roche has stopped dosing in a phase 3 trial of tominersen, a potential Huntington’s disease (HD) drug developed with Ionis, after a pre-planned review by independent experts.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results